Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
See detailLa prise en charge des patients Alzheimer au stade débutant
Juillerat, A. C.; Van der Linden, Martial ULg; Adam, Stéphane ULg et al

in Seron, X. (Ed.) Traité de neuropsychologie clinique : tome II (2000)

Detailed reference viewed: 167 (8 ULg)
See detailPrise en charge des patients lithiasiques
GADISSEUR, Romy ULg

Conference (2013, March 18)

Detailed reference viewed: 6 (5 ULg)
Full Text
Peer Reviewed
See detailPrise en charge des prolactinomes
VROONEN, Laurent ULg; Daly, Adrian ULg; Beckers, Albert ULg

in Revue Médicale Suisse (2013), 9

Detailed reference viewed: 7 (3 ULg)
See detailPrise en charge des Prolactinomes en 2009
Beckers, Albert ULg

Scientific conference (2009, November 14)

Detailed reference viewed: 7 (0 ULg)
See detailLa prise en charge des troubles de la mémoire chez les traumatisés crâniens
Adam, Stéphane ULg

Scientific conference (2001, November 10)

Detailed reference viewed: 2 (0 ULg)
See detailPrise en charge des troubles de la mémoire dans la maladie d'Alzheimer
Adam, Stéphane ULg

Conference given outside the academic context (2000)

Detailed reference viewed: 8 (0 ULg)
Peer Reviewed
See detailPrise en charge des urgences neurochirurgicales
Martin, Didier ULg

Conference (1996, October 23)

Detailed reference viewed: 13 (0 ULg)
Full Text
See detailPrise en charge du cancer pulmonaire non a petites cellules
Bosquee, Léon ULg; Frusch, Nicolas ULg; Louis, Renaud ULg

in Revue Médicale Suisse (2007), 3(122), 1890-5

Surgery, chemotherapy, radiotherapy and "biological" treatment are differently used in the treatment of non small cell lung cancer. Surgery is the cornerstone of the stages I-II treatment; chemotherapy is ... [more ▼]

Surgery, chemotherapy, radiotherapy and "biological" treatment are differently used in the treatment of non small cell lung cancer. Surgery is the cornerstone of the stages I-II treatment; chemotherapy is dominant in the treatment of metastatic stage, but is more and more used in earlier stages. A large discussion is still open for advanced non metastatic stages, even if the association of the 3 major modalities is extensively studied. We discuss our position in this setting. [less ▲]

Detailed reference viewed: 122 (5 ULg)
Full Text
Peer Reviewed
See detailPrise en charge du diabete gestationnel.
Philips, J. C.; EMONTS, Patrick ULg; Pintiaux, Axelle ULg et al

in Revue medicale de Liege (2013), 68(9), 489-96

Pregnancy is associated with relative carbohydrate intolerance and insulin resistance. Gestational diabetes mellitus (GDM) is recognized as a risk factor for a number of adverse outcomes during pregnancy ... [more ▼]

Pregnancy is associated with relative carbohydrate intolerance and insulin resistance. Gestational diabetes mellitus (GDM) is recognized as a risk factor for a number of adverse outcomes during pregnancy, including excessive fetal growth, increased incidence of birth trauma and neonatal metabolic abnormalities. This recognition has led to recommendations to screen all pregnant women for GDM and to treat those whose glucose tolerance tests exceed threshold criteria. Numerous epidemiological studies show that GDM affects between 1 and 25% of pregnancies, depending on the ethnicity of the population studied and the diagnostic criteria. Intervention to change lifestyle and, if maternal hyperglycemia persists, treatment with additional oral medication or insulin injections have shown to improve perinatal outcomes. Patients with GDM have a high risk of developing type 2 diabetes in the years after delivery and these women are encouraged to practice specific health behaviours (dietary habits, physical activity) during the postpartum period. The present article discusses the management of GDM in the light of data from the latest studies and international recommendations. [less ▲]

Detailed reference viewed: 44 (5 ULg)
Full Text
Peer Reviewed
See detailPrise en charge du lymphome B diffus à grandes cellules en 2012
Bonnet, Christophe ULg; DE PRIJCK, Bernard ULg; LEJEUNE, Marie ULg et al

in Revue Médicale Suisse (2012), 8

Diffuse Large B Cells Lymphoma (DLBCLI is the mast comman non-Hodgkin Iymphoma and comprises a large numberof different entities with different clinico-pathological characteristics. The role of positron ... [more ▼]

Diffuse Large B Cells Lymphoma (DLBCLI is the mast comman non-Hodgkin Iymphoma and comprises a large numberof different entities with different clinico-pathological characteristics. The role of positron emission tomography is essential dudog the Ini tial staging and post treatment assessment, and potentially at early or mid-treatmentevaluation of response. First-line therapy comprises immuno-chemotherapy with rituximab and different cytotox ic agents that differforcomponents, dosages and frequency of administration taking worldwlderecognized pre-treatment prognostic variables into account. After relapse, peripheral blood stem cells transplantation remains the only chance of cu re. This review attempts to summarize the current state of our knowledge by highlighting the leads pursued to further improve current therapeutic results. [less ▲]

Detailed reference viewed: 36 (6 ULg)
Full Text
Peer Reviewed
See detailPrise en charge du médulloblastome de l'enfant
Fransolet, A. C.; Born, J. D.; Misson, Jean-Paul ULg et al

in Revue Médicale de Liège (2007), 62(4), 200-4

We present the experience of the Citadelle Hospital (Liege, B) in the diagnosis, treatment and follow-up of medulloblastoma in children. A retrospective study of 10 cases of medulloblastoma was performed ... [more ▼]

We present the experience of the Citadelle Hospital (Liege, B) in the diagnosis, treatment and follow-up of medulloblastoma in children. A retrospective study of 10 cases of medulloblastoma was performed. Five years after diagnosis, the event-free survival was 77%. [less ▲]

Detailed reference viewed: 107 (1 ULg)
Full Text
See detailPrise en charge du nouveau-né en extra-hospitalier
VIELLEVOYE, Renaud ULg

Conference given outside the academic context (2010)

Detailed reference viewed: 7 (0 ULg)
See detailPrise en charge du patient brûlé en centre aigu.
ROUSSEAU, Anne-Françoise ULg

Scientific conference (2010, November)

Detailed reference viewed: 14 (2 ULg)
See detailLa prise en charge du patient cardiaque.
Etienne, Anne-Marie ULg

Scientific conference (2004, November 26)

Detailed reference viewed: 5 (0 ULg)
See detailPrise en charge du Prolactinome en 2009
Beckers, Albert ULg

Scientific conference (2009, November 27)

Detailed reference viewed: 16 (0 ULg)
Full Text
See detailPrise en charge du sportif lombalgique : analyse critique et perspectives
Vanderthommen, Marc ULg; Demoulin, Christophe ULg

in Abstract book du Congrès de l’Association Belge des Kinésithérapeutes du Sport « La Réathlétisation » (2008, May)

Detailed reference viewed: 76 (6 ULg)
See detailLa prise en charge en Centre de Jour de patients Alzheimer au stade débutant
Adam, Stéphane ULg

Scientific conference (1999, March 26)

Detailed reference viewed: 48 (2 ULg)